8 Coupons
-
Special Offer
-
30% off

erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
"we were quite surprised to find there were no significant differences," says study author .